Vext Science, Inc. (CSE:VEXT)
| Market Cap | 43.35M -30.0% |
| Revenue (ttm) | 75.12M +10.6% |
| Net Income | -23.63M |
| EPS | -0.10 |
| Shares Out | 247.71M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 40,200 |
| Open | 0.1800 |
| Previous Close | 0.1850 |
| Day's Range | 0.1600 - 0.1800 |
| 52-Week Range | 0.1600 - 0.4000 |
| Beta | 0.93 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 3, 2026 |
About Vext Science
Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, edibles, and extracts. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, Prism, Firebrand, and Revibe brand... [Read more]
Financial Performance
In 2025, Vext Science's revenue was $51.37 million, an increase of 42.69% compared to the previous year's $36.00 million. Losses were -$17.99 million, -19.79% less than in 2024.
Financial numbers in USD Financial StatementsNews
Vext Science Earnings Call Transcript: Q3 2026
Q3 revenue reached $14.9M, up 18% YoY, and operating cash flow doubled QoQ, but Adjusted EBITDA fell sharply as lower output and inventory costs pressured margins. Ohio growth and store expansion remain priorities as Arizona assets are repositioned.
Vext Science Report: Q3 2026
Vext Science published a report on November 3, 2026 containing material business information for investors and shareholders.
Vext Science MD&A: Q3 2026
Vext Science filed a regulatory document on November 3, 2026 disclosing important business information.
Vext Science Earnings release: Q3 2026
Vext Science released its Q3 2026 earnings on November 3, 2026, summarizing the period's financial results.
Vext Reports Q3 2026 Financial Results; Record Quarterly Revenue of $14.9 Million; Operating Cash Flow of $2.4 Million
Record quarterly revenue of $14.9 million, up 23% from Q2 2026 and 18% year-over-year. Ohio revenue up 37% year-over-year to $10.9 million, led by Fairfield and Company-grown flower.
Vext Announces Date for Q3 2026 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated c...
Vext Provides Update on Jackson, Ohio Dispensary
Vancouver, British Columbia--(Newsfile Corp. - October 15, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated c...
Vext Science Slides: Corporate presentation
Vext Science has posted slides in relation to its latest quarterly earnings report, which was published on October 13, 2026.
Vext Announces Reopening of Jackson, Ohio Dispensary and Restructuring of Ohio Seller Notes Ahead of December 2026 Maturity
Ohio Division of Cannabis Control authorizes reopening of Jackson dispensary effective September 17 Single-day obligation at maturity reduced from approximately US$5.6 million to US$2.4 million, payab...
Vext Provides Operational Update on Jackson, Ohio Dispensary
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated ...
Vext Science Earnings Call Transcript: Q2 2026
Q2 saw flat sequential revenue but improved margins and profitability, driven by Ohio retail growth and the Arizona cultivation exit. Net loss narrowed 80% year-over-year, and cash flow remained strong. Focus remains on Ohio expansion, Arizona repositioning, and debt reduction.
Vext Science MD&A: Q2 2026
Vext Science filed a regulatory document on August 20, 2026 disclosing important business information.
Vext Science Report: Q2 2026
Vext Science published a report on August 20, 2026 containing material business information for investors and shareholders.
Vext Science Earnings release: Q2 2026
Vext Science released its Q2 2026 earnings on August 20, 2026, summarizing the period's financial results.
Vext Reports Q2 2026 Financial Results; Opens Sixth Ohio Dispensary, Completes Arizona Cultivation Wind-Down; Adjusted EBITDA Grows for Second Consecutive Quarter
Revenue of $12.1 million, level with Q1 2026, as Ohio growth offset the planned Arizona cultivation wind-down. Adjusted EBITDA* of $3.4 million, up 22% from Q1 2026; net loss narrowed 79% year-over-ye...
Vext Announces Date for Q2 2026 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - August 12, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today anno...
Vext Opens Sixth Ohio Dispensary in Fairfield
A high-visibility location on one of the area's busiest retail corridors, anchored by neighboring Jungle Jim's International Market - expected to drive durable store-level performance. Vancouver, Brit...
Vext Science Earnings Call Transcript: Q1 2026
Revenue rose 5% year-over-year to $12.2M, led by Ohio's 34% growth, while Arizona declined 24% amid wholesale compression. Gross profit more than doubled, adjusted EBITDA margin improved to 29%, and net loss narrowed to $0.9M. Ohio retail expansion and Arizona streamlining remain key priorities.
Vext Science Earnings release: Q1 2026
Vext Science released its Q1 2026 earnings on May 21, 2026, summarizing the period's financial results.
Vext Science Report: Q1 2026
Vext Science published a report on May 21, 2026 containing material business information for investors and shareholders.
Vext Science MD&A: Q1 2026
Vext Science filed a regulatory document on May 21, 2026 disclosing important business information.
Vext Reports Q1 2026 Financial Results; Adjusted EBITDA up 73% Sequentially to $3.6 Million as Ohio Platform Scales
Revenue of $12.2 million, up 5.2% year-over-year; gross profit more than doubled to $5.5 million (45.4% margin), and net loss narrowed 73.2% to $(0.9) million. Operating cash flow of $1.6 million and ...
Vext Engages Zuanic & Associates
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with operations in Arizona and Ohi...
Vext Announces Date for Q1 2026 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today announc...
Vext Science Slides: Investor presentation
Vext Science has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.